Tramadol Hydrochloride
Product Images NDC 68071-2923

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68071-2923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2923 3)

Label for Tramadol Hydrochloride 200mg extended-release tablets, bottle of 30, manufactured by Sun Pharmaceutical Industries Ltd. and packaged by NuCare Pharmaceuticals, Inc. The label features dosage strength, quantity, controlled substance Schedule IV symbol, NDC 68071-2923, and warnings including storage instructions and a caution to keep out of reach of children.*

FDA Label Image

Tramadol-figure1 (Tramadol Figure1)

A line graph comparing plasma concentration over time of Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily versus Tramadol IR Tablets 50 mg every 6 hours. The x-axis shows time in hours (0 to 24), and the y-axis shows tramadol concentration in ng/mL. The graph depicts distinct concentration profiles for each formulation over 24 hours.*

FDA Label Image

Tramadol-figure2 (Tramadol Figure2)

A line chart comparing M1 concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol IR Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis shows M1 concentration levels.*

FDA Label Image

Tramadol-figure3 (Tramadol Figure3)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' illustrating the percent of patients achieving various levels of response threshold (percent improvement from baseline). The graph compares multiple doses of Tramadol Hydrochloride Extended-Release Tablets (100mg, 200mg, 300mg, 400mg) and placebo, showing percent of patients achieving response on the y-axis and response threshold on the x-axis.*

FDA Label Image

Tramadol-figure4 (Tramadol Figure4)

A line graph showing the percentage of patients achieving various response thresholds in a study of Tramadol Hydrochloride Extended-Release Tablets versus placebo for arthritis pain intensity. The x-axis represents response threshold as percent improvement from baseline, and the y-axis represents the percent of patients achieving response. Two lines compare the drug and placebo performance across thresholds.*

FDA Label Image

Tramadol-structure (Tramadol Structure)

Chemical structure of Tramadol Hydrochloride, showing its molecular arrangement including the methoxyphenyl group, hydroxyl, cyclohexane ring, dimethylamino group, and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.